Login

Christoph Vilanek is the CEO of Freenet. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Richard Knoll on the Seamless JMG Acquisition and its Benefits
00:10:00
Commerce Resources Announces Major Resource Estimate Update and Upcoming ASX Listing
00:10:00
Interview: Kolby on Building Value Habits | Jenn Steliga - Advisor of Time Well Spent Financial Coaching LLC
00:10:00
Challenges and Opportunities in the Modern Financial Landscape | Liz Gordon, Vice President ,  L Catterton.
00:10:00
Or Yissachar on IDF Insights and Challenges Facing Israel|Or Yissachar, Professor, Paris School of International Affairs
00:10:00
Transforming School Choice by 2030: Expanding Options and Improving Outcomes
00:10:00
Believes that creating something of true for the next generation|Omri Amirav-Drory,General Partner,NFX
00:10:00
Chalice Gold: Exploring New Frontiers in Gold and Mineral Development - Insights from Director Tim Goitre Mani at the One-to-One Mining Conference
00:10:00
Dynamic business strategies spanning|Arun Kumar,Managing Partner,Celesta (fka WRVI)
00:10:00
Helps entrepreneurs build companies to boldly transform|Lior Susan,Founding Partner,Eclipse Ventures
00:10:00
Rising Energy Prices: Impact on the Economy and Consumers
00:10:00
The Future of Medicine is Predictive|Stephanie Campbell,General Partner,The Artemis Fund

© 2017 - Neuhu+